A single molecular target that, when silenced, simultaneously prevents cognitive decline, muscle wasting, heart dysfunction, and systemic inflammation—that is not the premise of a speculative longevity theory but an experimental result now published in Science. The finding reframes aging-associated organ deterioration as, at least in part, a reversible failure of cellular housekeeping rather than an inevitable consequence of accumulated molecular damage.
The research identifies tissue-resident macrophages (TRMs) as key arbiters of organ aging, specifically through their diminished capacity to engulf and clear senescent neutrophils—a process called efferocytosis. As animals age, elevated signaling through the prostaglandin E2 receptor EP2 on TRMs impairs this clearance, allowing senescent neutrophils to accumulate and trigger paracrine stress in neighboring cells. Plasma proteomics pointed to the liver as a primary hub for this immune dysregulation. Genetically reducing EP2 activity in aged mice preserved mitochondrial function and prevented a broad constellation of age-related pathology: frailty, sarcopenia, adiposity, cardiac impairment, and cognitive decline. Crucially, elevated TRM EP2 expression and senescent neutrophil accumulation were also detected in aged and diseased human tissues—not only in mice—and pharmacologic EP2 inhibition was sufficient to restore youthful efferocytosis.
This work is potentially paradigm-shifting for several reasons. First, it positions an immunological mechanism—innate immune cell crosstalk—rather than intrinsic cellular senescence as a primary driver of multi-organ aging. Second, the breadth of phenotypes rescued by a single receptor intervention is remarkable and warrants cautious scrutiny; pleiotropic rescue in mouse models often fails to translate fully to humans. Third, EP2 is a druggable receptor with existing pharmacological tools, compressing the translational timeline. The human tissue validation strengthens biological plausibility, though causality in humans remains unestablished. Overall, this represents one of the more mechanistically complete and therapeutically actionable aging studies in recent years.
